{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T22:50:37Z","timestamp":1793573437047,"version":"4.5.0"},"reference-count":272,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG067913"],"award-info":[{"award-number":["AG067913"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK094721"],"award-info":[{"award-number":["DK094721"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK098655"],"award-info":[{"award-number":["DK098655"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006823","name":"Boston Childrens Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007877","name":"Joslin Diabetes Center","doi-asserted-by":"publisher","award":["DK031036"],"award-info":[{"award-number":["DK031036"]}],"id":[{"id":"10.13039\/100007877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007877","name":"Joslin Diabetes Center","doi-asserted-by":"publisher","award":["DK05545"],"award-info":[{"award-number":["DK05545"]}],"id":[{"id":"10.13039\/100007877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007877","name":"Joslin Diabetes Center","doi-asserted-by":"publisher","award":["DK121967"],"award-info":[{"award-number":["DK121967"]}],"id":[{"id":"10.13039\/100007877","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.molmet.2021.101304","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T10:15:34Z","timestamp":1626344134000},"page":"101304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":209,"special_numbering":"C","title":["Insulin action at a molecular level \u2013 100 years of progress"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2166-508X","authenticated-orcid":false,"given":"Morris F.","family":"White","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Ronald","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmet.2021.101304_bib1","series-title":"Insulin: A pacesetter for the shape of modern biomedical science and the nobel prize. Mol metab in press","author":"Flier","year":"2021"},{"issue":"8","key":"10.1016\/j.molmet.2021.101304_bib2","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1073\/pnas.68.8.1833","article-title":"Insulin receptors in the liver: specific binding of ( 125 I)insulin to the plasma membrane and its relation to insulin bioactivity","volume":"68","author":"Freychet","year":"1971","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"issue":"4529","key":"10.1016\/j.molmet.2021.101304_bib3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1126\/science.7031900","article-title":"Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor","volume":"215","author":"Kasuga","year":"1982","journal-title":"Science"},{"issue":"41","key":"10.1016\/j.molmet.2021.101304_bib4","doi-asserted-by":"crossref","first-page":"25830","DOI":"10.1016\/S0021-9258(18)47322-X","article-title":"Accurate and efficient cleavage of the human insulin proreceptor by the human proprotein-processing protease furin. Characterization and kinetic parameters using the purified, secreted soluble protease expressed by a recombinant baculovirus","volume":"269","author":"Bravo","year":"1994","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"10.1016\/j.molmet.2021.101304_bib5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/bies.201400190","article-title":"Insulin\/receptor binding: the last piece of the puzzle? What recent progress on the structure of the insulin\/receptor complex tells us (or not) about negative cooperativity and activation","volume":"37","author":"De Meyts","year":"2015","journal-title":"BioEssays"},{"key":"10.1016\/j.molmet.2021.101304_bib6","article-title":"Structure and function of the insulin receptor","author":"Whittaker","year":"2020"},{"issue":"5","key":"10.1016\/j.molmet.2021.101304_bib7","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1083\/jcb.201711047","article-title":"Visualization of ligand-induced transmembrane signaling in the full-length human insulin receptor","volume":"217","author":"Gutmann","year":"2018","journal-title":"The Journal of Cell Biology"},{"issue":"7699","key":"10.1016\/j.molmet.2021.101304_bib8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nature26153","article-title":"Structure of the insulin receptor-insulin complex by single-particle cryo-EM analysis","volume":"556","author":"Scapin","year":"2018","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.molmet.2021.101304_bib9","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/pro.3871","article-title":"Insulin and epidermal growth factor receptor family members share parallel activation mechanisms","volume":"29","author":"Ferguson","year":"2020","journal-title":"Protein Science"},{"key":"10.1016\/j.molmet.2021.101304_bib10","series-title":"Activation mechanism of the insulin receptor revealed by cryo-EM structure of the fully liganded receptor-ligand complex. Elife 8","author":"Uchikawa","year":"2019"},{"issue":"8","key":"10.1016\/j.molmet.2021.101304_bib11","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.tibs.2008.06.003","article-title":"The insulin receptor: a prototype for dimeric, allosteric membrane receptors?","volume":"33","author":"De Meyts","year":"2008","journal-title":"Trends in Biochemical Sciences"},{"issue":"5","key":"10.1016\/j.molmet.2021.101304_bib12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1210\/er.2017-00073","article-title":"Insulin receptor isoforms in physiology and disease: an updated view","volume":"38","author":"Belfiore","year":"2017","journal-title":"Endocrine Reviews"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib13","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/s41467-018-03219-7","article-title":"How ligand binds to the type 1 insulin-like growth factor receptor","volume":"9","author":"Xu","year":"2018","journal-title":"Nature Communications"},{"issue":"6005","key":"10.1016\/j.molmet.2021.101304_bib14","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/313756a0","article-title":"Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes","volume":"313","author":"Ullrich","year":"1985","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.molmet.2021.101304_bib15","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0092-8674(85)90334-4","article-title":"The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling","volume":"40","author":"Ebina","year":"1985","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.molmet.2021.101304_bib16","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1016\/S0021-9258(18)69163-X","article-title":"A\u00a0cascade of tyrosine autophosphorylation in the beta-subunit activates the phosphotransferase of the insulin receptor","volume":"263","author":"White","year":"1988","journal-title":"Journal of Biological Chemistry"},{"issue":"34","key":"10.1016\/j.molmet.2021.101304_bib17","doi-asserted-by":"crossref","first-page":"23068","DOI":"10.1016\/S0021-9258(18)54464-1","article-title":"Amino acid sequences Gly-Pro-Leu-Tyr and Asn-Pro-Glu-Tyr in the submembranous domain of the insulin receptor are required for normal endocytosis","volume":"266","author":"Rajagopalan","year":"1991","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib18","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.201907210","article-title":"Cryo-EM structure of the complete and ligand-saturated insulin receptor ectodomain","volume":"219","author":"Gutmann","year":"2020","journal-title":"Journal of Cell Biology"},{"issue":"6042","key":"10.1016\/j.molmet.2021.101304_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/318183a0","article-title":"Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells","volume":"318","author":"White","year":"1985","journal-title":"Nature"},{"issue":"6330","key":"10.1016\/j.molmet.2021.101304_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/352073a0","article-title":"Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein","volume":"352","author":"Sun","year":"1991","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.molmet.2021.101304_bib21","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s00125-002-0945-z","article-title":"Absence of functional insulin receptor substrate-3 (IRS-3) gene in humans","volume":"45","author":"Bjornholm","year":"2002","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.molmet.2013.10.004","article-title":"Irs2 and Irs4 synergize in non-LepRb neurons to control energy balance and glucose homeostasis","volume":"3","author":"Sadagurski","year":"2014","journal-title":"Molecular Metabolism"},{"issue":"10","key":"10.1016\/j.molmet.2021.101304_bib23","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s00125-012-2644-8","article-title":"Regulation of insulin sensitivity by serine\/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2","volume":"55","author":"Copps","year":"2012","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.molmet.2021.101304_bib24","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0092-8674(88)80008-4","article-title":"Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity","volume":"54","author":"White","year":"1988","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.molmet.2021.101304_bib25","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1002\/j.1460-2075.1992.tb05426.x","article-title":"Phosphatidylinositol 3'-kinase is activated by association with IRS-1 during insulin stimulation","volume":"11","author":"Backer","year":"1992","journal-title":"The EMBO Journal"},{"issue":"15","key":"10.1016\/j.molmet.2021.101304_bib26","doi-asserted-by":"crossref","first-page":"8378","DOI":"10.1073\/pnas.96.15.8378","article-title":"Crystal structure of the pleckstrin homology-phosphotyrosine binding (PH-PTB) targeting region of insulin receptor substrate 1","volume":"96","author":"Dhe-Paganon","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"key":"10.1016\/j.molmet.2021.101304_bib27","doi-asserted-by":"crossref","first-page":"14892","DOI":"10.1038\/ncomms14892","article-title":"Domain-dependent effects of insulin and IGF-1 receptors on signalling and gene expression","volume":"8","author":"Cai","year":"2017","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrc3860","article-title":"PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting","volume":"15","author":"Thorpe","year":"2015","journal-title":"Nature Reviews Cancer"},{"issue":"5573","key":"10.1016\/j.molmet.2021.101304_bib29","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","article-title":"The phosphoinositide 3-kinase pathway","volume":"296","author":"Cantley","year":"2002","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.molmet.2021.101304_bib30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrm3290","article-title":"PI3K signalling: the path to discovery and understanding","volume":"13","author":"Vanhaesebroeck","year":"2012","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"10.1016\/j.molmet.2021.101304_bib31","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13578-020-00416-0","article-title":"Roles of the PI3K\/AKT\/mTOR signalling pathways in neurodegenerative diseases and tumours","volume":"10","author":"Xu","year":"2020","journal-title":"Cell & Bioscience"},{"issue":"7","key":"10.1016\/j.molmet.2021.101304_bib32","first-page":"4902","article-title":"Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation","volume":"14","author":"Cheatham","year":"1994","journal-title":"Molecular and Cellular Biology"},{"issue":"7719","key":"10.1016\/j.molmet.2021.101304_bib33","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41586-018-0343-4","article-title":"Suppression of insulin feedback enhances the efficacy of PI3K inhibitors","volume":"560","author":"Hopkins","year":"2018","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.molmet.2021.101304_bib34","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.celrep.2015.07.016","article-title":"A\u00a0positive feedback loop between Akt and mTORC2 via SIN1 phosphorylation","volume":"12","author":"Yang","year":"2015","journal-title":"Cell Reports"},{"issue":"10","key":"10.1016\/j.molmet.2021.101304_bib35","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.cellsig.2011.05.004","article-title":"Akt signalling in health and disease","volume":"23","author":"Hers","year":"2011","journal-title":"Cellular Signalling"},{"issue":"3","key":"10.1016\/j.molmet.2021.101304_bib36","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nm.2686","article-title":"Insulin regulates liver metabolism in\u00a0vivo in the absence of hepatic Akt and Foxo1","volume":"18","author":"Lu","year":"2012","journal-title":"Nature Medicine"},{"issue":"5675","key":"10.1016\/j.molmet.2021.101304_bib37","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1126\/science.1096706","article-title":"A\u00a0family with severe insulin resistance and diabetes due to a mutation in AKT2","volume":"304","author":"George","year":"2004","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.molmet.2021.101304_bib38","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"issue":"5852","key":"10.1016\/j.molmet.2021.101304_bib39","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.1150653","article-title":"Cell signaling. mTOR, unleashed","volume":"318","author":"Proud","year":"2007","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.molmet.2021.101304_bib40","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/ncb2877","article-title":"Crosstalk between mTOR complexes","volume":"15","author":"Xie","year":"2013","journal-title":"Nature Cell Biology"},{"issue":"3","key":"10.1016\/j.molmet.2021.101304_bib41","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1101\/gad.209130.112","article-title":"mTOR complex 2 phosphorylates IMP1 cotranslationally to promote IGF2 production and the proliferation of mouse embryonic fibroblasts","volume":"27","author":"Dai","year":"2013","journal-title":"Genes & Development"},{"issue":"5","key":"10.1016\/j.molmet.2021.101304_bib42","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1210\/en.2018-00853","article-title":"Phosphorylation of Forkhead protein FoxO1 at S253 regulates glucose homeostasis in mice","volume":"160","author":"Zhang","year":"2019","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2021.101304_bib43","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/bs.ctdb.2017.10.006","article-title":"Regulation of FOXO factors in mammalian cells","volume":"127","author":"Brown","year":"2018","journal-title":"Current Topics in Developmental Biology"},{"issue":"2","key":"10.1016\/j.molmet.2021.101304_bib44","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1530\/JOE-17-0002","article-title":"FoxO integration of insulin signaling with glucose and lipid metabolism","volume":"233","author":"Lee","year":"2017","journal-title":"Journal of Endocrinology"},{"key":"10.1016\/j.molmet.2021.101304_bib45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.molmet.2018.09.011","article-title":"Regulation of glucose uptake and inflammation markers by FOXO1 and FOXO3 in skeletal muscle","volume":"20","author":"Lundell","year":"2019","journal-title":"Molecular Metabolism"},{"issue":"3","key":"10.1016\/j.molmet.2021.101304_bib46","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/db18-0416","article-title":"FoxO transcription factors are critical regulators of diabetes-related muscle atrophy","volume":"68","author":"O'Neill","year":"2019","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.molmet.2021.101304_bib47","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.molmet.2021.101304_bib48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.tem.2005.03.010","article-title":"FoxO proteins in insulin action and metabolism","volume":"16","author":"Barthel","year":"2005","journal-title":"Trends in Endocrinology and Metabolism"},{"issue":"14","key":"10.1016\/j.molmet.2021.101304_bib49","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJM197604012941401","article-title":"The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man","volume":"294","author":"Kahn","year":"1976","journal-title":"New England Journal of Medicine"},{"issue":"10","key":"10.1016\/j.molmet.2021.101304_bib50","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.2337\/db17-0301","article-title":"Structural basis and genotype-phenotype correlations of INSR mutations causing severe insulin resistance","volume":"66","author":"Hosoe","year":"2017","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.molmet.2021.101304_bib51","first-page":"315","article-title":"Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis","volume":"119","author":"Semple","year":"2009","journal-title":"Journal of Clinical Investigation"},{"issue":"9","key":"10.1016\/j.molmet.2021.101304_bib52","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ng.2383","article-title":"Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes","volume":"44","author":"Morris","year":"2012","journal-title":"Nature Genetics"},{"key":"10.1016\/j.molmet.2021.101304_bib53","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.physiol.68.040104.124723","article-title":"From mice to men: insights into the insulin resistance syndromes","volume":"68","author":"Biddinger","year":"2006","journal-title":"Annual Review of Physiology"},{"issue":"4","key":"10.1016\/j.molmet.2021.101304_bib54","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.cmet.2017.03.004","article-title":"Imbalanced insulin actions in obesity and type 2 diabetes: key mouse models of insulin signaling pathway","volume":"25","author":"Kubota","year":"2017","journal-title":"Cell Metabolism"},{"issue":"3","key":"10.1016\/j.molmet.2021.101304_bib55","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrendo.2012.258","article-title":"The role of hepatokines in metabolism","volume":"9","author":"Stefan","year":"2013","journal-title":"Nature Reviews Endocrinology"},{"issue":"7","key":"10.1016\/j.molmet.2021.101304_bib56","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/s41591-018-0048-0","article-title":"Inactivating hepatic follistatin alleviates hyperglycemia","volume":"24","author":"Tao","year":"2018","journal-title":"Nature Medicine"},{"issue":"11","key":"10.1016\/j.molmet.2021.101304_bib57","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1172\/JCI118705","article-title":"A\u00a0common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies","volume":"97","author":"Almind","year":"1996","journal-title":"Journal of Clinical Investigation"},{"issue":"8","key":"10.1016\/j.molmet.2021.101304_bib58","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/78693","article-title":"Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance","volume":"6","author":"Zisman","year":"2000","journal-title":"Nature Medicine"},{"issue":"7","key":"10.1016\/j.molmet.2021.101304_bib59","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1172\/JCI29027","article-title":"Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony","volume":"116","author":"Herman","year":"2006","journal-title":"Journal of Clinical Investigation"},{"issue":"5","key":"10.1016\/j.molmet.2021.101304_bib60","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1097-2765(00)80155-0","article-title":"A\u00a0muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance","volume":"2","author":"Bruning","year":"1998","journal-title":"Molecular Cell"},{"issue":"8","key":"10.1016\/j.molmet.2021.101304_bib61","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.celrep.2015.04.037","article-title":"Differential role of insulin\/IGF-1 receptor signaling in muscle growth and glucose homeostasis","volume":"11","author":"O'Neill","year":"2015","journal-title":"Cell Reports"},{"issue":"3","key":"10.1016\/j.molmet.2021.101304_bib62","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/MCB.00983-10","article-title":"Insulin receptor substrates Irs1 and Irs2 coordinate skeletal muscle growth and metabolism via the Akt and AMPK pathways","volume":"31","author":"Long","year":"2011","journal-title":"Molecular and Cellular Biology"},{"issue":"9","key":"10.1016\/j.molmet.2021.101304_bib63","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.2337\/dbi17-0007","article-title":"Targeting FXR and FGF19 to treat metabolic diseases-lessons learned from bariatric surgery","volume":"67","author":"Bozadjieva","year":"2018","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.molmet.2021.101304_bib64","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1172\/JCI86522","article-title":"Insulin and IGF-1 receptors regulate FoxO-mediated signaling in muscle proteostasis","volume":"126","author":"O'Neill","year":"2016","journal-title":"Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib65","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1097-2765(05)00015-8","article-title":"Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction","volume":"6","author":"Michael","year":"2000","journal-title":"Molecular Cell"},{"issue":"7","key":"10.1016\/j.molmet.2021.101304_bib66","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.tem.2017.03.003","article-title":"Unraveling the regulation of hepatic metabolism by insulin","volume":"28","author":"Titchenell","year":"2017","journal-title":"Trends in Endocrinology and Metabolism"},{"issue":"2","key":"10.1016\/j.molmet.2021.101304_bib67","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cmet.2007.11.013","article-title":"Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis","volume":"7","author":"Biddinger","year":"2008","journal-title":"Cell Metabolism"},{"issue":"4","key":"10.1016\/j.molmet.2021.101304_bib68","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1172\/JCI16426","article-title":"Insulin signaling is required for insulin's direct and indirect action on hepatic glucose production","volume":"111","author":"Fisher","year":"2003","journal-title":"Journal of Clinical Investigation"},{"issue":"4","key":"10.1016\/j.molmet.2021.101304_bib69","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz266","article-title":"Muscle-liver substrate fluxes in exercising humans and potential effects on hepatic metabolism","volume":"105","author":"Hu","year":"2020","journal-title":"Journal of Clinical Endocrinology Metabolism"},{"issue":"5","key":"10.1016\/j.molmet.2021.101304_bib70","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1210\/er.2017-00016","article-title":"Fibroblast growth factor 21-metabolic role in mice and men","volume":"38","author":"Staiger","year":"2017","journal-title":"Endocrine Reviews"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib71","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cmet.2008.06.006","article-title":"Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation","volume":"8","author":"Dong","year":"2008","journal-title":"Cell Metabolism"},{"issue":"11","key":"10.1016\/j.molmet.2021.101304_bib72","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1038\/nm.2049","article-title":"Foxo1 integrates insulin signaling with mitochondrial function in the liver","volume":"15","author":"Cheng","year":"2009","journal-title":"Nature Medicine"},{"issue":"18","key":"10.1016\/j.molmet.2021.101304_bib73","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1128\/MCB.00138-09","article-title":"The Irs1 branch of the insulin signaling cascade plays a dominant role in hepatic nutrient homeostasis","volume":"29","author":"Guo","year":"2009","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.molmet.2021.101304_bib74","doi-asserted-by":"crossref","first-page":"7079","DOI":"10.1038\/ncomms8079","article-title":"FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization","volume":"6","author":"I","year":"2015","journal-title":"Nature Communications"},{"issue":"6","key":"10.1016\/j.molmet.2021.101304_bib75","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.cmet.2016.04.022","article-title":"Direct hepatocyte insulin signaling is required for lipogenesis but is dispensable for the suppression of glucose production","volume":"23","author":"Titchenell","year":"2016","journal-title":"Cell Metabolism"},{"issue":"4","key":"10.1016\/j.molmet.2021.101304_bib76","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.cell.2015.01.012","article-title":"Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes","volume":"160","author":"Perry","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib77","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1534-5807(02)00199-5","article-title":"Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance","volume":"3","author":"Bluher","year":"2002","journal-title":"Developmental Cell"},{"issue":"8","key":"10.1016\/j.molmet.2021.101304_bib78","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.2337\/db16-0212","article-title":"Differential roles of insulin and IGF-1 receptors in adipose tissue development and function","volume":"65","author":"Boucher","year":"2016","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.molmet.2021.101304_bib79","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.2337\/db16-0213","article-title":"Lipodystrophy due to adipose tissue-specific insulin receptor knockout results in progressive NAFLD","volume":"65","author":"Softic","year":"2016","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.molmet.2021.101304_bib80","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.cmet.2016.12.008","article-title":"Adipocyte dynamics and reversible metabolic syndrome in mice with an inducible adipocyte-specific deletion of the insulin receptor","volume":"25","author":"Sakaguchi","year":"2017","journal-title":"Cell Metabolism"},{"issue":"5","key":"10.1016\/j.molmet.2021.101304_bib81","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1128\/MCB.01110-06","article-title":"Essential role of insulin and insulin-like growth factor 1 receptor signaling in cardiac development and function","volume":"27","author":"Laustsen","year":"2007","journal-title":"Molecular and Cellular Biology"},{"issue":"5","key":"10.1016\/j.molmet.2021.101304_bib82","doi-asserted-by":"crossref","first-page":"H747","DOI":"10.1152\/ajpheart.00849.2013","article-title":"The absence of insulin signaling in the heart induces changes in potassium channel expression and ventricular repolarization","volume":"306","author":"Lopez-Izquierdo","year":"2014","journal-title":"American Journal of Physiology - Heart and Circulatory Physiology"},{"issue":"4","key":"10.1016\/j.molmet.2021.101304_bib83","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.ATV.0000209500.15801.4e","article-title":"Regulation of vascular endothelial growth factor expression and vascularization in the myocardium by insulin receptor and PI3K\/Akt pathways in insulin resistance and ischemia","volume":"26","author":"He","year":"2006","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"6","key":"10.1016\/j.molmet.2021.101304_bib84","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.134920","article-title":"Insulin receptor substrates differentially exacerbate insulin-mediated left ventricular remodeling","volume":"5","author":"Riehle","year":"2020","journal-title":"JCI Insight"},{"issue":"7","key":"10.1016\/j.molmet.2021.101304_bib85","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1161\/CIRCRESAHA.116.306206","article-title":"Insulin signaling and heart failure","volume":"118","author":"Riehle","year":"2016","journal-title":"Circulation Research"},{"key":"10.1016\/j.molmet.2021.101304_bib86","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3389\/fimmu.2019.01101","article-title":"Vascular smooth muscle cells contribute to atherosclerosis immunity","volume":"10","author":"Hu","year":"2019","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib87","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1038\/s41467-019-12368-2","article-title":"Homozygous receptors for insulin and not IGF-1 accelerate intimal hyperplasia in insulin resistance and diabetes","volume":"10","author":"Li","year":"2019","journal-title":"Nature Communications"},{"issue":"5","key":"10.1016\/j.molmet.2021.101304_bib88","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cmet.2010.03.013","article-title":"Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice","volume":"11","author":"Rask-Madsen","year":"2010","journal-title":"Cell Metabolism"},{"issue":"5","key":"10.1016\/j.molmet.2021.101304_bib89","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1369\/jhc.4A6590.2005","article-title":"Attenuation of accumulation of neointimal lipid by pioglitazone in mice genetically deficient in insulin receptor substrate-2 and apolipoprotein E.","volume":"53","author":"Clough","year":"2005","journal-title":"Journal of Histochemistry and Cytochemistry"},{"issue":"3","key":"10.1016\/j.molmet.2021.101304_bib90","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.cmet.2011.01.018","article-title":"Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle","volume":"13","author":"Kubota","year":"2011","journal-title":"Cell Metabolism"},{"issue":"7","key":"10.1016\/j.molmet.2021.101304_bib91","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.2337\/db13-0246","article-title":"Direct autocrine action of insulin on beta-cells: does it make physiological sense?","volume":"62","author":"Rhodes","year":"2013","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.molmet.2021.101304_bib92","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0092-8674(00)80546-2","article-title":"Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes","volume":"96","author":"Kulkarni","year":"1999","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib93","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/12631","article-title":"Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling","volume":"23","author":"Withers","year":"1999","journal-title":"Nature Genetics"},{"issue":"5","key":"10.1016\/j.molmet.2021.101304_bib94","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1074\/jbc.M512373200","article-title":"RIP-Cre revisited, evidence for impairments of pancreatic beta-cell function","volume":"281","author":"Lee","year":"2006","journal-title":"Journal of Biological Chemistry"},{"issue":"11","key":"10.1016\/j.molmet.2021.101304_bib95","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.2337\/db11-0341","article-title":"Specific glucose-induced control of insulin receptor substrate-2 expression is mediated via Ca2+-dependent calcineurin\/NFAT signaling in primary pancreatic islet beta-cells","volume":"60","author":"Demozay","year":"2011","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.molmet.2021.101304_bib96","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1128\/MCB.01489-08","article-title":"Glucose effects on beta-cell growth and survival require activation of insulin receptors and insulin receptor substrate 2","volume":"29","author":"Assmann","year":"2009","journal-title":"Molecular and Cellular Biology"},{"issue":"2","key":"10.1016\/j.molmet.2021.101304_bib97","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1074\/jbc.M508307200","article-title":"Exendin-4 uses Irs2 signaling to mediate pancreatic beta cell growth and function","volume":"281","author":"Park","year":"2006","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.molmet.2021.101304_bib98","first-page":"A338","article-title":"Insulin receptor substrate-2 and PDX-1 act convergently to regulate beta cell mass in\u00a0vivo","volume":"50","author":"Kushner","year":"2001","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.molmet.2021.101304_bib99","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.80749","article-title":"Trimeprazine increases IRS2 in human islets and promotes pancreatic beta cell growth and function in mice","volume":"1","author":"Kuznetsova","year":"2016","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.molmet.2021.101304_bib100","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1152\/physrev.00032.2015","article-title":"Brain insulin resistance at the crossroads of metabolic and cognitive disorders in humans","volume":"96","author":"Kullmann","year":"2016","journal-title":"Physiological Reviews"},{"issue":"3","key":"10.1016\/j.molmet.2021.101304_bib101","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","article-title":"Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums","volume":"14","author":"Arnold","year":"2018","journal-title":"Nature Reviews Neurology"},{"issue":"6","key":"10.1016\/j.molmet.2021.101304_bib102","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/PSY.0000000000000212","article-title":"Obesity and aging: consequences for cognition, brain structure, and brain function","volume":"77","author":"Bischof","year":"2015","journal-title":"Psychosomatic Medicine"},{"issue":"33","key":"10.1016\/j.molmet.2021.101304_bib103","doi-asserted-by":"crossref","first-page":"23807","DOI":"10.1074\/jbc.M112.436279","article-title":"Nerve growth factor receptor TrkA, a new receptor in insulin signaling pathway in PC12 cells","volume":"288","author":"Geetha","year":"2013","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.molmet.2021.101304_bib104","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1146\/annurev.biochem.72.121801.161629","article-title":"Trk receptors: roles in neuronal signal transduction","volume":"72","author":"Huang","year":"2003","journal-title":"Annual Review of Biochemistry"},{"issue":"7","key":"10.1016\/j.molmet.2021.101304_bib105","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.2337\/db14-0568","article-title":"Insulin action in brain regulates systemic metabolism and brain function","volume":"63","author":"Kleinridders","year":"2014","journal-title":"Diabetes"},{"issue":"13","key":"10.1016\/j.molmet.2021.101304_bib106","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1073\/pnas.1817391116","article-title":"Insulin signaling in the hippocampus and amygdala regulates metabolism and neurobehavior","volume":"116","author":"Soto","year":"2019","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"issue":"4","key":"10.1016\/j.molmet.2021.101304_bib107","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"Journal of Clinical Investigation"},{"issue":"2","key":"10.1016\/j.molmet.2021.101304_bib108","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neurobiolaging.2008.04.002","article-title":"Defects in IGF-1 receptor, insulin receptor and IRS-1\/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling","volume":"31","author":"Moloney","year":"2010","journal-title":"Neurobiology of Aging"},{"issue":"4","key":"10.1016\/j.molmet.2021.101304_bib109","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI57256","article-title":"An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Abeta oligomers","volume":"122","author":"Bomfim","year":"2012","journal-title":"Journal of Clinical Investigation"},{"issue":"9","key":"10.1016\/j.molmet.2021.101304_bib110","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1073\/pnas.0308724101","article-title":"Role for neuronal insulin resistance in neurodegenerative diseases","volume":"101","author":"Schubert","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"issue":"6","key":"10.1016\/j.molmet.2021.101304_bib111","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.cmet.2013.11.002","article-title":"TNF-alpha mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by alzheimer's beta-amyloid oligomers in mice and monkeys","volume":"18","author":"Lourenco","year":"2013","journal-title":"Cell Metabolism"},{"issue":"6","key":"10.1016\/j.molmet.2021.101304_bib112","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1101\/lm.2111311","article-title":"Insulin receptor substrate 2 is a negative regulator of memory formation","volume":"18","author":"Irvine","year":"2011","journal-title":"Learning & Memory"},{"issue":"10","key":"10.1016\/j.molmet.2021.101304_bib113","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1096\/fj.09-132043","article-title":"Neuronal IGF-1 resistance reduces Abeta accumulation and protects against premature death in a model of Alzheimer's disease","volume":"23","author":"Freude","year":"2009","journal-title":"The FASEB Journal"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib114","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bbrc.2009.06.032","article-title":"Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice","volume":"386","author":"Killick","year":"2009","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"6","key":"10.1016\/j.molmet.2021.101304_bib115","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.cell.2009.11.014","article-title":"Reduced IGF-1 signaling delays age-associated proteotoxicity in mice","volume":"139","author":"Cohen","year":"2009","journal-title":"Cell"},{"issue":"6670","key":"10.1016\/j.molmet.2021.101304_bib116","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/36116","article-title":"Disruption of IRS-2 causes type 2 diabetes in mice","volume":"391","author":"Withers","year":"1998","journal-title":"Nature"},{"issue":"5836","key":"10.1016\/j.molmet.2021.101304_bib117","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1126\/science.1142179","article-title":"Brain IRS2 signaling coordinates life span and nutrient homeostasis","volume":"317","author":"Taguchi","year":"2007","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib118","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ecl.2012.11.008","article-title":"Integrating metabolism and longevity through insulin and IGF1 signaling","volume":"42","author":"Sadagurski","year":"2013","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"issue":"16 Suppl","key":"10.1016\/j.molmet.2021.101304_bib119","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/dom.12347","article-title":"IRS2 integrates insulin\/IGF1 signalling with metabolism, neurodegeneration and longevity","volume":"1","author":"White","year":"2014","journal-title":"Diabetes Obesity Metabolism"},{"issue":"10","key":"10.1016\/j.molmet.2021.101304_bib120","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1172\/JCI46305","article-title":"IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease","volume":"121","author":"Sadagurski","year":"2011","journal-title":"Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib121","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12701","article-title":"FOXO protects against age-progressive axonal degeneration","volume":"17","author":"Hwang","year":"2018","journal-title":"Aging Cell"},{"issue":"4","key":"10.1016\/j.molmet.2021.101304_bib122","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0092-8674(00)81896-6","article-title":"Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles","volume":"88","author":"Bruning","year":"1997","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.molmet.2021.101304_bib123","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.bbrc.2010.01.056","article-title":"Transcription factor AP-2beta: a negative regulator of IRS-1 gene expression","volume":"392","author":"Meng","year":"2010","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"7","key":"10.1016\/j.molmet.2021.101304_bib124","doi-asserted-by":"crossref","first-page":"e36961","DOI":"10.1371\/journal.pone.0036961","article-title":"The transcriptional coactivators p\/CIP and SRC-1 control insulin resistance through IRS1 in obesity models","volume":"7","author":"Wang","year":"2012","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.molmet.2021.101304_bib125","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10038-005-0253-9","article-title":"Genetic variations in the gene encoding TFAP2B are associated with type 2 diabetes mellitus","volume":"50","author":"Maeda","year":"2005","journal-title":"Journal of Human Genetics"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib126","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41467-019-08287-x","article-title":"TAZ couples Hippo\/Wnt signalling and insulin sensitivity through Irs1 expression","volume":"10","author":"Hwang","year":"2019","journal-title":"Nature Communications"},{"issue":"13","key":"10.1016\/j.molmet.2021.101304_bib127","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1101\/gad.1097103","article-title":"cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2","volume":"17","author":"Jhala","year":"2003","journal-title":"Genes & Development"},{"issue":"10","key":"10.1016\/j.molmet.2021.101304_bib128","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1073\/pnas.1815150116","article-title":"PGC1A regulates the IRS1:IRS2 ratio during fasting to influence hepatic metabolism downstream of insulin","volume":"116","author":"Besse-Patin","year":"2019","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"issue":"5","key":"10.1016\/j.molmet.2021.101304_bib129","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cmet.2005.09.008","article-title":"Dual role of the coactivator TORC2 in modulating hepatic glucose output and insulin signaling","volume":"2","author":"Canettieri","year":"2005","journal-title":"Cell Metabolism"},{"issue":"24","key":"10.1016\/j.molmet.2021.101304_bib130","doi-asserted-by":"crossref","first-page":"13656","DOI":"10.1073\/pnas.96.24.13656","article-title":"Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes","volume":"96","author":"Shimomura","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"issue":"4","key":"10.1016\/j.molmet.2021.101304_bib131","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ncb1111","article-title":"SREBPs suppress IRS-2-mediated insulin signalling in the liver","volume":"6","author":"Ide","year":"2004","journal-title":"Nature Cell Biology"},{"issue":"44","key":"10.1016\/j.molmet.2021.101304_bib132","doi-asserted-by":"crossref","first-page":"42394","DOI":"10.1074\/jbc.C200444200","article-title":"SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2","volume":"277","author":"Rui","year":"2002","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib133","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1745-7254.2008.00709.x","article-title":"Resistin induces insulin resistance, but does not affect glucose output in rat-derived hepatocytes","volume":"29","author":"Liu","year":"2008","journal-title":"Acta Pharmacologica Sinica"},{"issue":"4","key":"10.1016\/j.molmet.2021.101304_bib134","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.molcel.2008.03.009","article-title":"The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation","volume":"30","author":"Xu","year":"2008","journal-title":"Molecular Cell"},{"issue":"48","key":"10.1016\/j.molmet.2021.101304_bib135","doi-asserted-by":"crossref","first-page":"40758","DOI":"10.1074\/jbc.M112.405209","article-title":"Identification of the degradation determinants of insulin receptor substrate 1 for signaling cullin-RING E3 ubiquitin ligase 7-mediated ubiquitination","volume":"287","author":"Xu","year":"2012","journal-title":"Journal of Biological Chemistry"},{"issue":"11","key":"10.1016\/j.molmet.2021.101304_bib136","doi-asserted-by":"crossref","first-page":"7654","DOI":"10.1074\/jbc.M113.529925","article-title":"Myostatin induces insulin resistance via Casitas B-lineage lymphoma b (Cblb)-mediated degradation of insulin receptor substrate 1 (IRS1) protein in response to high calorie diet intake","volume":"289","author":"Bonala","year":"2014","journal-title":"Journal of Biological Chemistry"},{"issue":"18","key":"10.1016\/j.molmet.2021.101304_bib137","doi-asserted-by":"crossref","first-page":"12467","DOI":"10.1074\/jbc.M114.554162","article-title":"Insulin and metabolic stress stimulate multisite serine\/threonine phosphorylation of insulin receptor substrate 1 and inhibit tyrosine phosphorylation","volume":"289","author":"Hancer","year":"2014","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib138","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cmet.2009.11.003","article-title":"Irs1 serine 307 promotes insulin sensitivity in mice","volume":"11","author":"Copps","year":"2010","journal-title":"Cell Metabolism"},{"issue":"16","key":"10.1016\/j.molmet.2021.101304_bib139","doi-asserted-by":"crossref","first-page":"8602","DOI":"10.1074\/jbc.M116.714915","article-title":"Serine 302 phosphorylation of mouse insulin receptor substrate 1 (IRS1) is dispensable for normal insulin signaling and feedback regulation by hepatic S6 kinase","volume":"291","author":"Copps","year":"2016","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/j.molmet.2021.101304_bib140","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1742-4658.2012.08563.x","article-title":"PTP1B and TCPTP\u2013nonredundant phosphatases in insulin signaling and glucose homeostasis","volume":"280","author":"Tiganis","year":"2013","journal-title":"FEBS Journal"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib141","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2337\/diabetes.53.1.61","article-title":"Islet-sparing effects of protein tyrosine phosphatase-1b deficiency delays onset of diabetes in IRS2 knockout mice","volume":"53","author":"Kushner","year":"2004","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.molmet.2021.101304_bib142","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.tips.2015.07.003","article-title":"Protein tyrosine phosphatases in hypothalamic insulin and leptin signaling","volume":"36","author":"Zhang","year":"2015","journal-title":"Trends in Pharmacological Sciences"},{"issue":"11","key":"10.1016\/j.molmet.2021.101304_bib143","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1016\/j.celrep.2019.08.019","article-title":"Intranasal targeting of hypothalamic PTP1B and TCPTP reinstates leptin and insulin sensitivity and promotes weight loss in obesity","volume":"28","author":"Dodd","year":"2019","journal-title":"Cell Reports"},{"issue":"2","key":"10.1016\/j.molmet.2021.101304_bib144","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.semcdb.2003.12.021","article-title":"Human cancer, PTEN and the PI-3 kinase pathway","volume":"15","author":"Parsons","year":"2004","journal-title":"Seminars in Cell & Developmental Biology"},{"issue":"2","key":"10.1016\/j.molmet.2021.101304_bib145","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1096\/fj.201800529RR","article-title":"Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activity","volume":"33","author":"Polianskyte-Prause","year":"2019","journal-title":"The FASEB Journal"},{"issue":"2","key":"10.1016\/j.molmet.2021.101304_bib146","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.bbrc.2004.02.082","article-title":"Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation","volume":"316","author":"Carlson","year":"2004","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"12","key":"10.1016\/j.molmet.2021.101304_bib147","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19123705","article-title":"MicroRNAs as regulators of insulin signaling: research updates and potential therapeutic perspectives in type 2 diabetes","volume":"19","author":"Nigi","year":"2018","journal-title":"International Journal of Molecular Science"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib148","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cell.2011.08.033","article-title":"The Lin28\/let-7 axis regulates glucose metabolism","volume":"147","author":"Zhu","year":"2011","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.molmet.2021.101304_bib149","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.bbrc.2018.07.084","article-title":"Saturated fatty acids-induced miR-424-5p aggravates insulin resistance via targeting insulin receptor in hepatocytes","volume":"503","author":"Min","year":"2018","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"11","key":"10.1016\/j.molmet.2021.101304_bib150","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1002\/mnfr.201500107","article-title":"Obesity-induced miR-15b is linked causally to the development of insulin resistance through the repression of the insulin receptor in hepatocytes","volume":"59","author":"Yang","year":"2015","journal-title":"Molecular Nutrition & Food Research"},{"issue":"21","key":"10.1016\/j.molmet.2021.101304_bib151","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1016\/j.febslet.2014.09.006","article-title":"Saturated fatty acid-induced miR-195 impairs insulin signaling and glycogen metabolism in HepG2 cells","volume":"588","author":"Yang","year":"2014","journal-title":"FEBS Letters"},{"issue":"12","key":"10.1016\/j.molmet.2021.101304_bib152","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169039","article-title":"Induction of miR-96 by Dietary Saturated Fatty Acids Exacerbates Hepatic Insulin Resistance through the Suppression of INSR and IRS-1","volume":"11","author":"Yang","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib153","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191553","article-title":"Identification of microRNA that represses IRS-1 expression in liver","volume":"13","author":"Ono","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.molmet.2021.101304_bib154","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.bbrc.2014.02.034","article-title":"MiRNA-145 is involved in the development of resistin-induced insulin resistance in HepG2 cells","volume":"445","author":"Wen","year":"2014","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"7","key":"10.1016\/j.molmet.2021.101304_bib155","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2337\/db17-0141","article-title":"Altered miR-29 expression in type 2 diabetes influences glucose and lipid metabolism in skeletal muscle","volume":"66","author":"Massart","year":"2017","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.molmet.2021.101304_bib156","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149954","article-title":"MiR-126 Suppresses the Glucose-Stimulated Proliferation via IRS-2 in INS-1 beta Cells","volume":"11","author":"Tao","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.molmet.2021.101304_bib157","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.bbadis.2013.03.021","article-title":"miR-135a targets IRS2 and regulates insulin signaling and glucose uptake in the diabetic gastrocnemius skeletal muscle","volume":"1832","author":"Agarwal","year":"2013","journal-title":"Biochimica et Biophysica Acta"},{"issue":"9","key":"10.1016\/j.molmet.2021.101304_bib158","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1046\/j.1365-2362.1999.00522.x","article-title":"Advancing age and insulin resistance: new facts about an ancient history","volume":"29","author":"Paolisso","year":"1999","journal-title":"European Journal of Clinical Investigation"},{"issue":"12","key":"10.1016\/j.molmet.2021.101304_bib159","doi-asserted-by":"crossref","first-page":"909","DOI":"10.7326\/0003-4819-113-12-909","article-title":"Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents","volume":"113","author":"Warram","year":"1990","journal-title":"Annals of Internal Medicine"},{"issue":"19","key":"10.1016\/j.molmet.2021.101304_bib160","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJM198805123181901","article-title":"Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians","volume":"318","author":"Lillioja","year":"1988","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1016\/j.molmet.2021.101304_bib161","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/0026-0495(90)90130-5","article-title":"Diminished insulin sensitivity and increased insulin response in nonobese, nondiabetic Mexican Americans","volume":"39","author":"Haffner","year":"1990","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib162","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0002-9343(76)90536-2","article-title":"Nonketotic diabetes mellitus: insulin deficiency or insulin resistance?","volume":"60","author":"Reaven","year":"1976","journal-title":"Americas Journal of Medicine"},{"issue":"2","key":"10.1016\/j.molmet.2021.101304_bib163","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nature Reviews Immunology"},{"issue":"7785","key":"10.1016\/j.molmet.2021.101304_bib164","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41586-019-1797-8","article-title":"The integrative biology of type 2 diabetes","volume":"576","author":"Roden","year":"2019","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.molmet.2021.101304_bib165","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiological Reviews"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib166","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1073\/pnas.71.1.84","article-title":"Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture","volume":"71","author":"Gavin","year":"1974","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib167","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cmet.2008.05.007","article-title":"Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding","volume":"8","author":"Kubota","year":"2008","journal-title":"Cell Metabolism"},{"issue":"6","key":"10.1016\/j.molmet.2021.101304_bib168","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.cmet.2012.10.019","article-title":"Hyperinsulinemia drives diet-induced obesity independently of brain insulin production","volume":"16","author":"Mehran","year":"2012","journal-title":"Cell Metabolism"},{"issue":"3","key":"10.1016\/j.molmet.2021.101304_bib169","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1096\/fj.201700518R","article-title":"Reducing insulin via conditional partial gene ablation in adults reverses diet-induced weight gain","volume":"32","author":"Page","year":"2018","journal-title":"The FASEB Journal"},{"issue":"4","key":"10.1016\/j.molmet.2021.101304_bib170","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","article-title":"A\u00a0branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance","volume":"9","author":"Newgard","year":"2009","journal-title":"Cell Metabolism"},{"issue":"6035","key":"10.1016\/j.molmet.2021.101304_bib171","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1126\/science.1199484","article-title":"Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling","volume":"332","author":"Yu","year":"2011","journal-title":"Science"},{"issue":"19","key":"10.1016\/j.molmet.2021.101304_bib172","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1056\/NEJMcibr1910023","article-title":"Nonalcoholic fatty liver disease, insulin resistance, and ceramides","volume":"381","author":"Samuel","year":"2019","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib173","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.celrep.2013.08.039","article-title":"Analysis of in\u00a0vitro insulin-resistance models and their physiological relevance to in\u00a0vivo diet-induced adipose insulin resistance","volume":"5","author":"Lo","year":"2013","journal-title":"Cell Reports"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib174","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm.2277","article-title":"Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin","volume":"17","author":"Holland","year":"2011","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib175","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/2044-5040-3-25","article-title":"MG53's new identity","volume":"3","author":"Levy","year":"2013","journal-title":"Skeletal Muscle"},{"issue":"4","key":"10.1016\/j.molmet.2021.101304_bib176","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrendo.2014.12","article-title":"Obesity: a complex role for adipose tissue macrophages","volume":"10","author":"Reilly","year":"2014","journal-title":"Nature Reviews Endocrinology"},{"issue":"4","key":"10.1016\/j.molmet.2021.101304_bib177","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.cmet.2018.12.007","article-title":"Exercise-induced changes in visceral adipose tissue mass are regulated by IL-6 signaling: a randomized controlled trial","volume":"29","author":"Wedell-Neergaard","year":"2019","journal-title":"Cell Metabolism"},{"issue":"6","key":"10.1016\/j.molmet.2021.101304_bib178","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.cmet.2012.03.001","article-title":"Insulin resistance in the defense against obesity","volume":"15","author":"Saltiel","year":"2012","journal-title":"Cell Metabolism"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib179","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1172\/JCI29881","article-title":"Obesity induces a phenotypic switch in adipose tissue macrophage polarization","volume":"117","author":"Lumeng","year":"2007","journal-title":"Journal of Clinical Investigation"},{"issue":"6","key":"10.1016\/j.molmet.2021.101304_bib180","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1053\/j.gastro.2007.03.059","article-title":"Obesity, inflammation, and insulin resistance","volume":"132","author":"Shoelson","year":"2007","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.molmet.2021.101304_bib181","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nrrheum.2014.193","article-title":"Exercise as an anti-inflammatory therapy for rheumatic diseases-myokine regulation","volume":"11","author":"Benatti","year":"2015","journal-title":"Nature Reviews Rheumatology"},{"issue":"3","key":"10.1016\/j.molmet.2021.101304_bib182","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00125-009-1580-8","article-title":"Human IL6 enhances leptin action in mice","volume":"53","author":"Sadagurski","year":"2010","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.molmet.2021.101304_bib183","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1128\/MCB.24.12.5434-5446.2004","article-title":"Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms","volume":"24","author":"Ueki","year":"2004","journal-title":"Molecular and Cellular Biology"},{"issue":"11","key":"10.1016\/j.molmet.2021.101304_bib184","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1172\/JCI28898","article-title":"TLR4 links innate immunity and fatty acid-induced insulin resistance","volume":"116","author":"Shi","year":"2006","journal-title":"Journal of Clinical Investigation"},{"issue":"4","key":"10.1016\/j.molmet.2021.101304_bib185","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1152\/physrev.00015.2006","article-title":"Endoplasmic reticulum stress signaling in disease","volume":"86","author":"Marciniak","year":"2006","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.molmet.2021.101304_bib186","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1146\/annurev.biochem.73.011303.074134","article-title":"The mammalian unfolded protein response","volume":"74","author":"Schroder","year":"2005","journal-title":"Annual Review of Biochemistry"},{"issue":"6","key":"10.1016\/j.molmet.2021.101304_bib187","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.cmet.2008.04.011","article-title":"Dephosphorylation of translation initiation factor 2alpha enhances glucose tolerance and attenuates hepatosteatosis in mice","volume":"7","author":"Oyadomari","year":"2008","journal-title":"Cell Metabolism"},{"issue":"5695","key":"10.1016\/j.molmet.2021.101304_bib188","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1126\/science.1103160","article-title":"Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes","volume":"306","author":"Ozcan","year":"2004","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.molmet.2021.101304_bib189","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nm.2293","article-title":"Regulation of glucose homeostasis through a XBP-1-FoxO1 interaction","volume":"17","author":"Zhou","year":"2011","journal-title":"Nature Medicine"},{"issue":"3","key":"10.1016\/j.molmet.2021.101304_bib190","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.devcel.2018.04.023","article-title":"The UPR activator ATF6 responds to proteotoxic and lipotoxic stress by distinct mechanisms","volume":"46","author":"Tam","year":"2018","journal-title":"Developmental Cell"},{"issue":"5","key":"10.1016\/j.molmet.2021.101304_bib191","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.cell.2015.05.011","article-title":"Treatment of obesity with celastrol","volume":"161","author":"Liu","year":"2015","journal-title":"Cell"},{"issue":"5790","key":"10.1016\/j.molmet.2021.101304_bib192","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1126\/science.1128294","article-title":"Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes","volume":"313","author":"Ozcan","year":"2006","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.molmet.2021.101304_bib193","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1210\/jc.2008-1001","article-title":"Endoplasmic reticulum stress markers are associated with obesity in nondiabetic subjects","volume":"93","author":"Sharma","year":"2008","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"4","key":"10.1016\/j.molmet.2021.101304_bib194","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0026-0495(98)90050-6","article-title":"Insulin resistance and fat patterning with aging: relationship to metabolic risk factors for cardiovascular disease","volume":"47","author":"Cefalu","year":"1998","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.molmet.2021.101304_bib195","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.cmet.2008.04.004","article-title":"Beneficial effects of subcutaneous fat transplantation on metabolism","volume":"7","author":"Tran","year":"2008","journal-title":"Cell Metabolism"},{"issue":"11","key":"10.1016\/j.molmet.2021.101304_bib196","doi-asserted-by":"crossref","first-page":"E1756","DOI":"10.1210\/jc.2011-0615","article-title":"Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity","volume":"96","author":"McLaughlin","year":"2011","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"5","key":"10.1016\/j.molmet.2021.101304_bib197","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1172\/JCI114880","article-title":"Beta-adrenoceptor expression in human fat cells from different regions","volume":"86","author":"Arner","year":"1990","journal-title":"Journal of Clinical Investigation"},{"issue":"1 Pt 1","key":"10.1016\/j.molmet.2021.101304_bib198","first-page":"E72","article-title":"Visceral adiposity, increased adipocyte lipolysis, and metabolic dysfunction in obese postmenopausal women","volume":"270","author":"Nicklas","year":"1996","journal-title":"American Journal of Physiology"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib199","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1172\/JCI77812","article-title":"The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux","volume":"126","author":"Samuel","year":"2016","journal-title":"Journal of Clinical Investigation"},{"issue":"60 Suppl","key":"10.1016\/j.molmet.2021.101304_bib200","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1575-0922(13)70026-3","article-title":"Adipose tissue expandability, lipotoxicity and the metabolic syndrome","volume":"1","author":"Vidal-Puig","year":"2013","journal-title":"Endocrinology Nutrition"},{"issue":"1\u20132","key":"10.1016\/j.molmet.2021.101304_bib201","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.mce.2009.11.011","article-title":"The autocrine and paracrine roles of adipokines","volume":"318","author":"Karastergiou","year":"2010","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"15","key":"10.1016\/j.molmet.2021.101304_bib202","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa0810780","article-title":"Identification and importance of brown adipose tissue in adult humans","volume":"360","author":"Cypess","year":"2009","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.molmet.2021.101304_bib203","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fendo.2015.00071","article-title":"Shades of brown: a model for thermogenic fat","volume":"6","author":"Dempersmier","year":"2015","journal-title":"Frontiers in Endocrinology"},{"issue":"5","key":"10.1016\/j.molmet.2021.101304_bib204","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1161\/ATVBAHA.119.313806","article-title":"High Brown fat activity correlates with cardiovascular risk factor levels cross-sectionally and subclinical atherosclerosis at 5-year follow-up","volume":"40","author":"Raiko","year":"2020","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"8","key":"10.1016\/j.molmet.2021.101304_bib205","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.2337\/diabetes.48.8.1600","article-title":"Intramyocellular triglyceride content is a determinant of in\u00a0vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents","volume":"48","author":"Perseghin","year":"1999","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.molmet.2021.101304_bib206","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.2337\/diabetes.48.6.1270","article-title":"Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade","volume":"48","author":"Griffin","year":"1999","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.molmet.2021.101304_bib207","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1053\/meta.2001.22512","article-title":"Increased protein kinase C theta in skeletal muscle of diabetic patients","volume":"50","author":"Itani","year":"2001","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.molmet.2021.101304_bib208","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/eci.1971.1.4.248","article-title":"Concentration of triglycerides, phospholipids and glycogen in skeletal muscle and of free fatty acids and beta-hydroxybutyric acid in blood in man in response to exercise","volume":"1","author":"Carlson","year":"1971","journal-title":"European Journal of Clinical Investigation"},{"issue":"4","key":"10.1016\/j.molmet.2021.101304_bib209","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0749-0690(18)30585-8","article-title":"Effect of physical activity on age-related glucose intolerance","volume":"6","author":"Laws","year":"1990","journal-title":"Clinics in Geriatric Medicine"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1475-097X.1982.tb00001.x","article-title":"Significance of skeletal muscle oxidative enzyme enhancement with endurance training","volume":"2","author":"Gollnick","year":"1982","journal-title":"Clinical Physiology"},{"issue":"6 Pt 1","key":"10.1016\/j.molmet.2021.101304_bib211","first-page":"E791","article-title":"Increased plasma FFA uptake and oxidation during prolonged exercise in trained vs. untrained humans","volume":"262","author":"Turcotte","year":"1992","journal-title":"American Journal of Physiology"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib212","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1152\/jappl.1993.75.1.108","article-title":"1993. Strenuous endurance training increases lipolysis and triglyceride-fatty acid cycling at rest","volume":"75","author":"Romijn","year":"1985","journal-title":"Journal of Applied Physiology"},{"issue":"5","key":"10.1016\/j.molmet.2021.101304_bib213","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1152\/jappl.1996.81.5.2182","article-title":"1996. Effects of training duration on substrate turnover and oxidation during exercise","volume":"81","author":"Phillips","year":"1985","journal-title":"Journal of Applied Physiology"},{"issue":"16","key":"10.1016\/j.molmet.2021.101304_bib214","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1113\/JP274374","article-title":"Training alters the distribution of perilipin proteins in muscle following acute free fatty acid exposure","volume":"595","author":"Shepherd","year":"2017","journal-title":"Journal of Physiology"},{"issue":"11","key":"10.1016\/j.molmet.2021.101304_bib215","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","article-title":"The global NAFLD epidemic","volume":"10","author":"Loomba","year":"2013","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"issue":"11","key":"10.1016\/j.molmet.2021.101304_bib216","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1172\/JCI94585","article-title":"Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling","volume":"127","author":"Softic","year":"2017","journal-title":"Journal of Clinical Investigation"},{"issue":"5","key":"10.1016\/j.molmet.2021.101304_bib217","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1007\/s10620-016-4054-0","article-title":"Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease","volume":"61","author":"Softic","year":"2016","journal-title":"Digestive Diseases and Sciences"},{"issue":"6","key":"10.1016\/j.molmet.2021.101304_bib218","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.2337\/diabetes.53.6.1412","article-title":"Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes","volume":"53","author":"Schrauwen","year":"2004","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.molmet.2021.101304_bib219","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.tem.2003.09.002","article-title":"Insulin regulation of mitochondrial proteins and oxidative phosphorylation in human muscle","volume":"14","author":"Boirie","year":"2003","journal-title":"Trends in Endocrinology and Metabolism"},{"issue":"3","key":"10.1016\/j.molmet.2021.101304_bib220","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nature Genetics"},{"issue":"14","key":"10.1016\/j.molmet.2021.101304_bib221","doi-asserted-by":"crossref","first-page":"8466","DOI":"10.1073\/pnas.1032913100","article-title":"Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1","volume":"100","author":"Patti","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"issue":"10","key":"10.1016\/j.molmet.2021.101304_bib222","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.2337\/diabetes.51.10.2944","article-title":"Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes","volume":"51","author":"Kelley","year":"2002","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib223","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/db12-0466","article-title":"Acylcarnitines: reflecting or inflicting insulin resistance?","volume":"62","author":"Schooneman","year":"2013","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.molmet.2021.101304_bib224","doi-asserted-by":"crossref","first-page":"297","DOI":"10.14348\/molcells.2015.0020","article-title":"Is acetylation a metabolic rheostat that regulates skeletal muscle insulin action?","volume":"38","author":"LaBarge","year":"2015","journal-title":"Molecular Cell"},{"issue":"7285","key":"10.1016\/j.molmet.2021.101304_bib225","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nature08778","article-title":"SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation","volume":"464","author":"Hirschey","year":"2010","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.molmet.2021.101304_bib226","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.2337\/db12-1650","article-title":"Sirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation","volume":"62","author":"Jing","year":"2013","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.molmet.2021.101304_bib227","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.tem.2012.07.004","article-title":"Mitochondrial sirtuins: regulators of protein acylation and metabolism","volume":"23","author":"He","year":"2012","journal-title":"Trends in Endocrinology and Metabolism"},{"issue":"51","key":"10.1016\/j.molmet.2021.101304_bib228","doi-asserted-by":"crossref","first-page":"42436","DOI":"10.1074\/jbc.R112.404863","article-title":"Mitochondrial protein acylation and intermediary metabolism: regulation by sirtuins and implications for metabolic disease","volume":"287","author":"Newman","year":"2012","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"10.1016\/j.molmet.2021.101304_bib229","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11154-014-9296-6","article-title":"Skeletal muscle glucose metabolism and inflammation in the development of the metabolic syndrome","volume":"15","author":"Marette","year":"2014","journal-title":"Reviews in Endocrine & Metabolic Disorders"},{"issue":"2","key":"10.1016\/j.molmet.2021.101304_bib230","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1172\/JCI116226","article-title":"Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus","volume":"91","author":"Del Prato","year":"1993","journal-title":"Journal of Clinical Investigation"},{"issue":"5","key":"10.1016\/j.molmet.2021.101304_bib231","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1172\/JCI113758","article-title":"Impaired insulin-stimulated muscle glycogen synthase activation in\u00a0vivo in man is related to low fasting glycogen synthase phosphatase activity","volume":"82","author":"Freymond","year":"1988","journal-title":"Journal of Clinical Investigation"},{"issue":"12","key":"10.1016\/j.molmet.2021.101304_bib232","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1172\/JCI118742","article-title":"Mechanism of free fatty acid-induced insulin resistance in humans","volume":"97","author":"Roden","year":"1996","journal-title":"Journal of Clinical Investigation"},{"issue":"16","key":"10.1016\/j.molmet.2021.101304_bib233","doi-asserted-by":"crossref","first-page":"10464","DOI":"10.1074\/jbc.272.16.10464","article-title":"13C and 31P NMR studies on the effects of increased plasma free fatty acids on intramuscular glucose metabolism in the awake rat","volume":"272","author":"Jucker","year":"1997","journal-title":"Journal of Biological Chemistry"},{"issue":"10","key":"10.1016\/j.molmet.2021.101304_bib234","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1172\/JCI0214955","article-title":"Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes","volume":"109","author":"Hundal","year":"2002","journal-title":"Journal of Clinical Investigation"},{"issue":"6","key":"10.1016\/j.molmet.2021.101304_bib235","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-152-6-201003160-00004","article-title":"The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial","volume":"152","author":"Goldfine","year":"2010","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib236","first-page":"E1","article-title":"Malonyl-CoA, fuel sensing, and insulin resistance","volume":"276","author":"Ruderman","year":"1999","journal-title":"American Journal of Physiology"},{"issue":"3 Suppl","key":"10.1016\/j.molmet.2021.101304_bib237","doi-asserted-by":"crossref","first-page":"500S","DOI":"10.1093\/ajcn\/67.3.500S","article-title":"Glucose-fatty acid interactions in health and disease","volume":"67","author":"McGarry","year":"1998","journal-title":"American Journal of Clinical Nutrition"},{"issue":"10","key":"10.1016\/j.molmet.2021.101304_bib238","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1043-2760(00)00331-3","article-title":"Malonyl-CoA and satiety? Food for thought","volume":"11","author":"McGarry","year":"2000","journal-title":"Trends in Endocrinology and Metabolism"},{"issue":"Pt 3","key":"10.1016\/j.molmet.2021.101304_bib239","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1042\/bj3350513","article-title":"Roles of the N- and C-terminal domains of carnitine palmitoyltransferase I isoforms in malonyl-CoA sensitivity of the enzymes: insights from expression of chimaeric proteins and mutation of conserved histidine residues","volume":"335","author":"Swanson","year":"1998","journal-title":"Biochemical Journal"},{"issue":"6","key":"10.1016\/j.molmet.2021.101304_bib240","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1172\/JCI114935","article-title":"Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependent diabetes mellitus","volume":"86","author":"Kelley","year":"1990","journal-title":"Journal of Clinical Investigation"},{"issue":"6","key":"10.1016\/j.molmet.2021.101304_bib241","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1172\/JCI117600","article-title":"Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus","volume":"94","author":"Kelley","year":"1994","journal-title":"Journal of Clinical Investigation"},{"issue":"7","key":"10.1016\/j.molmet.2021.101304_bib242","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.2337\/diabetes.49.7.1078","article-title":"Fatty acid oxidation and the regulation of malonyl-CoA in human muscle","volume":"49","author":"Bavenholm","year":"2000","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.molmet.2021.101304_bib243","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/MOG.0000000000000139","article-title":"The gut microbiome in health and in disease","volume":"31","author":"Shreiner","year":"2015","journal-title":"Current Opinion in Gastroenterology"},{"issue":"3","key":"10.1016\/j.molmet.2021.101304_bib244","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cmet.2015.07.007","article-title":"Interactions between gut microbiota, host genetics and diet modulate the predisposition to obesity and metabolic syndrome","volume":"22","author":"Ussar","year":"2015","journal-title":"Cell Metabolism"},{"issue":"6","key":"10.1016\/j.molmet.2021.101304_bib245","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1172\/JCI58109","article-title":"Gut microbiome, obesity, and metabolic dysfunction. J.Clin","volume":"121","author":"Tilg","year":"2011","journal-title":"Invest"},{"issue":"12","key":"10.1016\/j.molmet.2021.101304_bib246","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1172\/JCI86674","article-title":"Antibiotic effects on gut microbiota and metabolism are host dependent","volume":"126","author":"Fujisaka","year":"2016","journal-title":"Journal of Clinical Investigation"},{"issue":"7612","key":"10.1016\/j.molmet.2021.101304_bib247","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature18646","article-title":"Human gut microbes impact host serum metabolome and insulin sensitivity","volume":"535","author":"Pedersen","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.molmet.2021.101304_bib248","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/MOP.0000000000000234","article-title":"Influence of the human intestinal microbiome on obesity and metabolic dysfunction","volume":"27","author":"Tilg","year":"2015","journal-title":"Current Opinion in Pediatrics"},{"issue":"7606","key":"10.1016\/j.molmet.2021.101304_bib249","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nature18309","article-title":"Acetate mediates a microbiome-brain-beta-cell axis to promote metabolic syndrome","volume":"534","author":"Perry","year":"2016","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.molmet.2021.101304_bib250","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1053\/j.gastro.2014.02.008","article-title":"Role of the microbiome in energy regulation and metabolism","volume":"146","author":"Nieuwdorp","year":"2014","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.molmet.2021.101304_bib251","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.molmet.2016.07.004","article-title":"Interactions between host genetics and gut microbiome in diabetes and metabolic syndrome","volume":"5","author":"Ussar","year":"2016","journal-title":"Mol Metab"},{"issue":"2","key":"10.1016\/j.molmet.2021.101304_bib252","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cmet.2015.07.009","article-title":"Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation","volume":"22","author":"Tremaroli","year":"2015","journal-title":"Cell Metabolism"},{"issue":"10","key":"10.1016\/j.molmet.2021.101304_bib253","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1172\/JCI78366","article-title":"The microbiome revolution","volume":"124","author":"Blaser","year":"2014","journal-title":"Journal of Clinical Investigation"},{"issue":"6","key":"10.1016\/j.molmet.2021.101304_bib254","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nri.2016.42","article-title":"Gut microbiota, metabolites and host immunity","volume":"16","author":"Rooks","year":"2016","journal-title":"Nature Reviews Immunology"},{"issue":"4","key":"10.1016\/j.molmet.2021.101304_bib255","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.cell.2016.10.020","article-title":"Linking the human gut microbiome to inflammatory cytokine production capacity","volume":"167","author":"Schirmer","year":"2016","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.molmet.2021.101304_bib256","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00592-011-0333-6","article-title":"Gut microbiota and diabetes: from pathogenesis to therapeutic perspective","volume":"48","author":"Burcelin","year":"2011","journal-title":"Acta Diabetologica"},{"issue":"6150","key":"10.1016\/j.molmet.2021.101304_bib257","doi-asserted-by":"crossref","first-page":"1241214","DOI":"10.1126\/science.1241214","article-title":"Gut microbiota from twins discordant for obesity modulate metabolism in mice","volume":"341","author":"Ridaura","year":"2013","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.molmet.2021.101304_bib258","doi-asserted-by":"crossref","first-page":"7421","DOI":"10.1073\/pnas.1323599111","article-title":"Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut","volume":"111","author":"Joyce","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"issue":"9","key":"10.1016\/j.molmet.2021.101304_bib259","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/CIRCRESAHA.115.307409","article-title":"Contribution of gut bacteria to lipid levels: another metabolic role for microbes?","volume":"117","author":"Allayee","year":"2015","journal-title":"Circulation Research"},{"issue":"14","key":"10.1016\/j.molmet.2021.101304_bib260","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/eurheartj\/eht467","article-title":"The gut microbiome as novel cardio-metabolic target: the time has come!","volume":"35","author":"Vinje","year":"2014","journal-title":"European Heart Journal"},{"issue":"11","key":"10.1016\/j.molmet.2021.101304_bib261","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1016\/j.celrep.2018.02.060","article-title":"Diet, genetics, and the gut microbiome drive dynamic changes in plasma metabolites","volume":"22","author":"Fujisaka","year":"2018","journal-title":"Cell Reports"},{"issue":"5","key":"10.1016\/j.molmet.2021.101304_bib262","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.cmet.2012.01.024","article-title":"Interplay between lipids and branched-chain amino acids in development of insulin resistance","volume":"15","author":"Newgard","year":"2012","journal-title":"Cell Metabolism"},{"issue":"5","key":"10.1016\/j.molmet.2021.101304_bib263","doi-asserted-by":"crossref","first-page":"e10883","DOI":"10.1371\/journal.pone.0010883","article-title":"alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population","volume":"5","author":"Gall","year":"2010","journal-title":"PloS One"},{"issue":"12","key":"10.1016\/j.molmet.2021.101304_bib264","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.2337\/db13-0570","article-title":"Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach","volume":"62","author":"Menni","year":"2013","journal-title":"Diabetes"},{"issue":"8825","key":"10.1016\/j.molmet.2021.101304_bib265","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0140-6736(92)92814-V","article-title":"Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study","volume":"340","author":"Martin","year":"1992","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.molmet.2021.101304_bib266","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nm.4350","article-title":"Insulin action and resistance in obesity and type 2 diabetes","volume":"23","author":"Czech","year":"2017","journal-title":"Nature Medicine"},{"issue":"3","key":"10.1016\/j.molmet.2021.101304_bib267","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1172\/JCI7535","article-title":"Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle","volume":"105","author":"Cusi","year":"2000","journal-title":"Journal of Clinical Investigation"},{"issue":"2","key":"10.1016\/j.molmet.2021.101304_bib268","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2337\/db12-0337","article-title":"Constitutive STAT3 phosphorylation contributes to skeletal muscle insulin resistance in type 2 diabetes","volume":"62","author":"Mashili","year":"2013","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.molmet.2021.101304_bib269","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.cmet.2020.08.007","article-title":"A\u00a0cell-autonomous signature of dysregulated protein phosphorylation underlies muscle insulin resistance in type 2 diabetes","volume":"32","author":"Batista","year":"2020","journal-title":"Cell Metabolism"},{"issue":"43","key":"10.1016\/j.molmet.2021.101304_bib270","doi-asserted-by":"crossref","first-page":"30337","DOI":"10.1074\/jbc.274.43.30337","article-title":"Signal transduction pathways that regulate eukaryotic protein synthesis","volume":"274","author":"Rhoads","year":"1999","journal-title":"Journal of Biological Chemistry"},{"issue":"24","key":"10.1016\/j.molmet.2021.101304_bib271","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1101\/gad.12.24.3872","article-title":"The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families","volume":"12","author":"Kamura","year":"1998","journal-title":"Genes & Development"},{"issue":"4","key":"10.1016\/j.molmet.2021.101304_bib272","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0960-9822(99)80090-6","article-title":"A\u00a0direct interaction between the adaptor protein Cbl-b and the kinase zap-70 induces a positive signal in T cells","volume":"9","author":"Zhang","year":"1999","journal-title":"Current Biology"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877821001514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877821001514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:27:41Z","timestamp":1761956861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877821001514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":272,"alternative-id":["S2212877821001514"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2021.101304","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin action at a molecular level \u2013 100 years of progress","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2021.101304","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101304"}}